title: Effects of morning versus evening intake of atorvastatin on major cardiac event and restenosis rates in patients undergoing first elective percutaneous coronary intervention.
abstract: It is not known whether taking atorvastatin in the morning versus in the evening has a different effect on major cardiac event and restenosis rates in patients undergoing percutaneous coronary intervention. Therefore, the aim of the present study was to investigate the effects of morning versus evening intake of atorvastatin on major cardiac events and restenosis rates and also on serum lipid and high sensitivity C-reactive protein levels in patients with single-vessel disease who underwent first elective percutaneous coronary intervention.
authors.affiliation: Department of Public Health, Suleyman Demirel University, Isparta, Turkey. mehmetozaydin@hotmail.com
authors.forename: Mehmet
authors.initials: M
authors.lastname: Ozaydin
authors.forename: Ozkan
authors.initials: O
authors.lastname: Dede
authors.forename: Abdullah
authors.initials: A
authors.lastname: Dogan
authors.forename: Suleyman M
authors.initials: SM
authors.lastname: Aslan
authors.forename: Ahmet
authors.initials: A
authors.lastname: Altinbas
authors.forename: Mustafa
authors.initials: M
authors.lastname: Ozturk
authors.forename: Ercan
authors.initials: E
authors.lastname: Varol
authors.forename: Yasin
authors.initials: Y
authors.lastname: Turker
mesh_terms: D000368:Aged; D000787:Angina Pectoris / Q000453:epidemiology; D015906:Angioplasty, Balloon, Coronary; D000069059:Atorvastatin; D002097:C-Reactive Protein / Q000032:analysis; D019454:Chronotherapy; D023903:Coronary Restenosis / Q000453:epidemiology / Q000517:prevention & control*; D023921:Coronary Stenosis / Q000628:therapy; D005260:Female; D006538:Heptanoic Acids / Q000008:administration & dosage*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000453:epidemiology; D011446:Prospective Studies; D011758:Pyrroles / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids; D011758:Pyrroles; D002097:C-Reactive Protein; D000069059:Atorvastatin